The supply crisis of six menopause drugs leaves thousands of women without alternatives for their hormone therapy
The Medicines Agency says several companies refused to include their treatments in public funding. Scientific societies meet this Friday with the regulator
We haven't written up this one. El Pais has the full story — the link below goes straight to it.